Many MedTech companies decide to first target their home geographic market, building on their familiarity with it. Yet, a multitude of factors – such as competition, market value, probability of reimbursement, regulatory framework, cultural differences – are to be considered to fully capture the commercial potential. This session will focus on the US market with the aim of providing practical guidance on how to successfully first enter or expand into the US market. Why is it interesting to access the United States market and what makes it relevant in certain cases to give this market priority? What is the best timing to enter the US market? What are the main differences and common points between US and Europe markets?
Moderator: Charlotte Puechmaille, Country Manager France, Kranus Health 
